Accelerating Process Development through Outsourcing

The biopharmaceutical industry has dramatically reduced timelines over the last 10 years through new technologies and processes. To deliver on the urgency of a pandemic, innovators will need to rely on the wealth of expertise in the industry, including CROs and CDMOs, to challenging everything on the critical path to the clinic. Establishing and managing strategic partnerships capable of comprehensive analytics and integrated CRO/CDMO activities will be central to success.